| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.3 |